Research@UIC > Life Sciences Initiative > Presentation Guide

Presentation Guide

• Presentations are limited to twenty (20) minutes.  Suggested times for each section are listed below presentation guide summary.
• Handouts with references (e.g., charts, data) should be available for the listeners to help facilitate the discussion.
• No font should be less than 22 points in size.
• Each line will have keywords only (no sentences).
• There should be no more than 8 lines per slide (excluding the title).
• No slides with charts of data should be presented, but the data can be presented in handouts.  Graphs may be appropriate but colors do not show up well unless there is a high color contrast between the items and the lines or bars are “thick.” 
• No proprietary information should be presented.
• This Power Point is the preferred template, but a Power Point that presents the same topics is acceptable.  All slides must have a light background with a dark font type.  If there are slides with video, they should be incorporated into the Power Point slide and play without manipulation at the time of the presentation.

Slide 1: Title

Slide 2: Problem (5 Minutes)

• Clinical/Therapeutic Relevance – the issue of what is the problem to be solved must be first identified and placed in a larger context. 
• Brief Review – relevant background information should be given here.  If there are additional points that would make the understanding of the field more complete in which this research falls, it should be placed on the handout for later reference by the listener.

Slide 3: Where we are in the Process (5 minutes)

Placement of the arrow depicting where the researcher's work fits in three perspectives:

• Regulatory Perspective
• Commercialization Perspective
• Research Perspective

A detailed explanation of where you are in each area perspective should be outlined here.     Understanding the drug discovery process is key to working with the Pharmaceutical, Biotech, CRO, and CMO companies.  Guidance/help is available if this process is unclear.

Slide 4: Overview (5 minutes)

• General Results and Conclusions – the significance of the findings should be placed in context of its relevance to the overall goal of the laboratory.  Information should be presented at a high level.  If specific data is essential, this should be included in the handouts for the listeners. 
• No proprietary information should be presented - coordination between the researcher and the Technology Transfer Office at the presenter’s university will determine what information can be discusssed.
• Brief Discussion of Future Projects – short-term and long-term plans of the project assuming all things turn out the way they are expected (problems that are likely to occur along the way should be discussed under Challenges).
• Time Lines – overview of what is planned to move the research from the lab to the clinic (i.e., moving from basic exploratory research to highly focused clinical research).  The issue of funding from governmental agencies  (e.g., NIH, SBIR, etc.) and private sources (e.g., Private Equity, Foundations) should be briefly addressed.

Slide 5: Challenges (3 minutes)

• Field Related – high level review of general problems that the field is experiencing.
• Laboratory Related (what do we need) – what kind of outside assistance would be helpful in moving the research along.

Slide 6:  Strengths (2 minutes)

Slide 7:  Questions?

Presentation Guide Summary

Slide 1:  Title
Slide 2:  Problem (5 minutes)
Slide 3:  Process (5 minutes)
Slide 4:  Overview (5 minutes)
Slide 5:  Challenges (3 minutes)
Slide 6:  Strengths (2 minutes)
Slide 7:  Questions?